Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. NVDA
6. IBM
7. PRIM
8. SPY
9. ACN
10. BLZE

Go back to Pacira Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
PACIRA (NASDAQ: PCRX) Delayed: 23.50 +0.79 (3.48%)
Previous Close $22.71    52 Week High $80.25 
Open $22.90    52 Week Low $30.25 
Day High $23.51    P/E N/A 
Day Low $22.81    EPS $-2.08 
Volume 119,458